NASDAQ:GMDA
Delisted

Gamida Cell Stock Predictions

etoro logo Buy GMDA
*Your capital is at risk
$0.0327
+0 (+0%)
At Close: Aug 27, 2024
Currently predicting for Mon, 8 Jun 2026

GMDA Prediction Chart

GMDA Predictions History

Latest community submissions for GMDA.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 7, 2024 $0.364 +3.94% $0.337 X 91.90% 0
Mar 7, 2024 $0.359 +2.46% $0.337 X 93.43% 0
JS JS Pro
Mar 7, 2024 $0.346 -1.28% $0.337 V 97.33% 1
Jan 24, 2024 $0.380 +21.52% $0.350 V 91.43% 1
JS JS Pro
Apr 24, 2023 $1.59 -0.63% $1.65 X 96.36% 0
AlexVel AlexVel Pro
Apr 24, 2023 $1.45 -9.38% $1.65 X 87.88% 0
Apr 24, 2023 $1.52 -5.03% $1.65 X 92.09% 0
Apr 24, 2023 $1.55 -3.14% $1.65 X 93.92% 0
AlexVel AlexVel Pro
Feb 16, 2023 $1.43 +0.88% $1.43 V 99.82% 6
JS JS Pro
Nov 15, 2022 $1.90 -3.31% $1.89 V 99.47% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GMDA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GAMIDA CELL LTD.
Gamida Cell
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based can...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE